Titre : Techniques bactériologiques

Techniques bactériologiques : Questions médicales fréquentes

Termes MeSH sélectionnés :

Programmed Cell Death 1 Receptor
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Techniques bactériologiques : Questions médicales les plus fréquentes", "headline": "Techniques bactériologiques : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Techniques bactériologiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-01", "dateModified": "2025-04-26", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Techniques bactériologiques" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Techniques microbiologiques", "url": "https://questionsmedicales.fr/mesh/D008828", "about": { "@type": "MedicalCondition", "name": "Techniques microbiologiques", "code": { "@type": "MedicalCode", "code": "D008828", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E05.200.875" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Techniques de typage bactérien", "alternateName": "Bacterial Typing Techniques", "url": "https://questionsmedicales.fr/mesh/D015373", "about": { "@type": "MedicalCondition", "name": "Techniques de typage bactérien", "code": { "@type": "MedicalCode", "code": "D015373", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E05.200.875.150.125" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Lysotypie", "alternateName": "Bacteriophage Typing", "url": "https://questionsmedicales.fr/mesh/D001434", "about": { "@type": "MedicalCondition", "name": "Lysotypie", "code": { "@type": "MedicalCode", "code": "D001434", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E05.200.875.150.125.150" } } } ] }, { "@type": "MedicalWebPage", "name": "Test LAL", "alternateName": "Limulus Test", "url": "https://questionsmedicales.fr/mesh/D008033", "about": { "@type": "MedicalCondition", "name": "Test LAL", "code": { "@type": "MedicalCode", "code": "D008033", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E05.200.875.150.570" } } } ], "about": { "@type": "MedicalCondition", "name": "Techniques bactériologiques", "alternateName": "Bacteriological Techniques", "code": { "@type": "MedicalCode", "code": "D001431", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "A Yu Mironov", "url": "https://questionsmedicales.fr/author/A%20Yu%20Mironov", "affiliation": { "@type": "Organization", "name": "G.N. Gabrichevsky Research Institute for Epidemiology and Microbiology." } }, { "@type": "Person", "name": "O Yu Borisova", "url": "https://questionsmedicales.fr/author/O%20Yu%20Borisova", "affiliation": { "@type": "Organization", "name": "G.N. Gabrichevsky Research Institute of Epidemiology and Microbiology." } }, { "@type": "Person", "name": "N T Gadua", "url": "https://questionsmedicales.fr/author/N%20T%20Gadua", "affiliation": { "@type": "Organization", "name": "G.N. Gabrichevsky Research Institute of Epidemiology and Microbiology." } }, { "@type": "Person", "name": "A S Pimenova", "url": "https://questionsmedicales.fr/author/A%20S%20Pimenova", "affiliation": { "@type": "Organization", "name": "G.N. Gabrichevsky Research Institute of Epidemiology and Microbiology." } }, { "@type": "Person", "name": "S S Afanasiev", "url": "https://questionsmedicales.fr/author/S%20S%20Afanasiev", "affiliation": { "@type": "Organization", "name": "G.N. Gabrichevsky Research Institute of Epidemiology and Microbiology." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Programmed cell death-1 blockade therapy in melanoma: Resistance mechanisms and combination strategies.", "datePublished": "2023-01-24", "url": "https://questionsmedicales.fr/article/36645031", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/exd.14750" } }, { "@type": "ScholarlyArticle", "name": "MicroRNAs Targeting Programmed Cell Death Protein 1 (PD-1) Promote Natural Killer Cell Exhaustion in Rheumatoid Arthritis.", "datePublished": "2022-12-24", "url": "https://questionsmedicales.fr/article/36640056", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.18502/ijaai.v21i6.11524" } }, { "@type": "ScholarlyArticle", "name": "Differential expression of programmed death 1 (PD-1) on various immune cells and its role in human leprosy.", "datePublished": "2023-04-21", "url": "https://questionsmedicales.fr/article/37153623", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fimmu.2023.1138145" } }, { "@type": "ScholarlyArticle", "name": "A High Programmed Cell Death Protein 1 Hormone Receptor Score on Skin Biopsy is Associated with Sézary Syndrome Diagnosis: A Study of 91 Patients with Erythroderma.", "datePublished": "2022-09-06", "url": "https://questionsmedicales.fr/article/35758515", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2340/actadv.v102.1062" } }, { "@type": "ScholarlyArticle", "name": "Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.", "datePublished": "2022-11-25", "url": "https://questionsmedicales.fr/article/36442821", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.actbio.2022.11.043" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Techniques d'investigation", "item": "https://questionsmedicales.fr/mesh/D008919" }, { "@type": "ListItem", "position": 3, "name": "Techniques de laboratoire clinique", "item": "https://questionsmedicales.fr/mesh/D019411" }, { "@type": "ListItem", "position": 4, "name": "Techniques microbiologiques", "item": "https://questionsmedicales.fr/mesh/D008828" }, { "@type": "ListItem", "position": 5, "name": "Techniques bactériologiques", "item": "https://questionsmedicales.fr/mesh/D001431" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Techniques bactériologiques - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Techniques bactériologiques", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Techniques bactériologiques", "description": "Comment se fait l'isolement des bactéries ?\nQu'est-ce qu'un test de sensibilité aux antibiotiques ?\nQuels milieux sont utilisés pour la culture bactérienne ?\nComment identifier une bactérie pathogène ?\nQu'est-ce qu'une coloration de Gram ?", "url": "https://questionsmedicales.fr/mesh/D001431?mesh_terms=Programmed+Cell+Death+1+Receptor&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Techniques bactériologiques", "description": "Quels symptômes indiquent une infection bactérienne ?\nComment reconnaître une septicémie ?\nQuels signes d'infection cutanée bactérienne ?\nQuels symptômes d'une pneumonie bactérienne ?\nQuels symptômes d'une infection urinaire ?", "url": "https://questionsmedicales.fr/mesh/D001431?mesh_terms=Programmed+Cell+Death+1+Receptor&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Techniques bactériologiques", "description": "Comment prévenir les infections bactériennes ?\nQuel rôle des vaccins dans la prévention ?\nPourquoi l'hygiène des mains est-elle importante ?\nComment éviter les infections nosocomiales ?\nQuel est l'impact de l'alimentation sur les infections ?", "url": "https://questionsmedicales.fr/mesh/D001431?mesh_terms=Programmed+Cell+Death+1+Receptor&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Techniques bactériologiques", "description": "Quels antibiotiques sont couramment utilisés ?\nComment se déroule un traitement antibiotique ?\nQu'est-ce que la thérapie combinée ?\nComment traiter une infection cutanée ?\nQuelles sont les alternatives aux antibiotiques ?", "url": "https://questionsmedicales.fr/mesh/D001431?mesh_terms=Programmed+Cell+Death+1+Receptor&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Techniques bactériologiques", "description": "Quelles sont les complications d'une infection non traitée ?\nQuels risques d'une résistance aux antibiotiques ?\nComment une infection peut-elle affecter le cœur ?\nQuelles complications d'une pneumonie bactérienne ?\nQuels effets d'une infection sur le système nerveux ?", "url": "https://questionsmedicales.fr/mesh/D001431?mesh_terms=Programmed+Cell+Death+1+Receptor&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Techniques bactériologiques", "description": "Quels sont les facteurs de risque d'infections bactériennes ?\nComment le tabagisme influence-t-il les infections ?\nQuel impact du diabète sur les infections ?\nPourquoi les personnes âgées sont-elles à risque ?\nQuel rôle joue l'hygiène dans le risque d'infection ?", "url": "https://questionsmedicales.fr/mesh/D001431?mesh_terms=Programmed+Cell+Death+1+Receptor&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment se fait l'isolement des bactéries ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'isolement se fait par culture sur milieux spécifiques pour favoriser la croissance." } }, { "@type": "Question", "name": "Qu'est-ce qu'un test de sensibilité aux antibiotiques ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "C'est un test qui détermine l'efficacité d'antibiotiques sur des bactéries isolées." } }, { "@type": "Question", "name": "Quels milieux sont utilisés pour la culture bactérienne ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des milieux comme le milieu nutritif, le milieu de MacConkey ou le milieu de Sabouraud." } }, { "@type": "Question", "name": "Comment identifier une bactérie pathogène ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Par des tests biochimiques, des colorations et des techniques moléculaires." } }, { "@type": "Question", "name": "Qu'est-ce qu'une coloration de Gram ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "C'est une méthode de coloration qui permet de classer les bactéries en Gram positif ou négatif." } }, { "@type": "Question", "name": "Quels symptômes indiquent une infection bactérienne ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, douleur, rougeur, gonflement et parfois écoulement purulent." } }, { "@type": "Question", "name": "Comment reconnaître une septicémie ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Par une fièvre élevée, des frissons, une fréquence cardiaque rapide et confusion." } }, { "@type": "Question", "name": "Quels signes d'infection cutanée bactérienne ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Rougeur, chaleur, douleur, gonflement et parfois formation de pus." } }, { "@type": "Question", "name": "Quels symptômes d'une pneumonie bactérienne ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Toux, fièvre, douleurs thoraciques et difficultés respiratoires." } }, { "@type": "Question", "name": "Quels symptômes d'une infection urinaire ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Brûlures à la miction, besoin fréquent d'uriner et douleurs abdominales." } }, { "@type": "Question", "name": "Comment prévenir les infections bactériennes ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Par une bonne hygiène, vaccination et évitement des contacts avec des malades." } }, { "@type": "Question", "name": "Quel rôle des vaccins dans la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccins stimulent le système immunitaire pour prévenir certaines infections bactériennes." } }, { "@type": "Question", "name": "Pourquoi l'hygiène des mains est-elle importante ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Elle réduit la transmission des bactéries et prévient les infections." } }, { "@type": "Question", "name": "Comment éviter les infections nosocomiales ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Par des protocoles stricts d'hygiène et de désinfection dans les établissements de santé." } }, { "@type": "Question", "name": "Quel est l'impact de l'alimentation sur les infections ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée renforce le système immunitaire et aide à prévenir les infections." } }, { "@type": "Question", "name": "Quels antibiotiques sont couramment utilisés ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Pénicillines, céphalosporines, macrolides et fluoroquinolones." } }, { "@type": "Question", "name": "Comment se déroule un traitement antibiotique ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Il doit être prescrit par un médecin et suivi jusqu'à la fin pour éviter la résistance." } }, { "@type": "Question", "name": "Qu'est-ce que la thérapie combinée ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Utilisation de plusieurs antibiotiques pour traiter des infections complexes." } }, { "@type": "Question", "name": "Comment traiter une infection cutanée ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Par des antibiotiques topiques ou oraux selon la gravité de l'infection." } }, { "@type": "Question", "name": "Quelles sont les alternatives aux antibiotiques ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Probiotiques, phagothérapie et traitements immunomodulateurs." } }, { "@type": "Question", "name": "Quelles sont les complications d'une infection non traitée ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Septicémie, choc septique, et défaillance d'organes peuvent survenir." } }, { "@type": "Question", "name": "Quels risques d'une résistance aux antibiotiques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Infections plus difficiles à traiter, augmentation de la morbidité et mortalité." } }, { "@type": "Question", "name": "Comment une infection peut-elle affecter le cœur ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut provoquer une endocardite, une inflammation des valves cardiaques." } }, { "@type": "Question", "name": "Quelles complications d'une pneumonie bactérienne ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Abcès pulmonaire, pleurésie et détresse respiratoire aiguë." } }, { "@type": "Question", "name": "Quels effets d'une infection sur le système nerveux ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Peut entraîner des méningites ou des encéphalites, avec des conséquences graves." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque d'infections bactériennes ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Âge avancé, immunodépression, diabète et hospitalisation prolongée." } }, { "@type": "Question", "name": "Comment le tabagisme influence-t-il les infections ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Il affaiblit le système immunitaire et augmente le risque d'infections respiratoires." } }, { "@type": "Question", "name": "Quel impact du diabète sur les infections ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Le diabète augmente le risque d'infections cutanées et urinaires en raison de l'immunité affaiblie." } }, { "@type": "Question", "name": "Pourquoi les personnes âgées sont-elles à risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Leur système immunitaire est souvent affaibli, rendant les infections plus probables." } }, { "@type": "Question", "name": "Quel rôle joue l'hygiène dans le risque d'infection ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Une mauvaise hygiène augmente le risque de transmission des bactéries pathogènes." } } ] } ] }

Sources (10000 au total)

Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.

Immune checkpoint blockade therapy targeting programmed death-1 (PD-1) or its major ligand programmed death-ligand 1 (PD-L1) has achieved remarkable success in the treatment of several tumors, includi...

Clinical Benefit of First-Line Programmed Death-1 Antibody Plus Chemotherapy in Low Programmed Cell Death Ligand 1-Expressing Esophageal Squamous Cell Carcinoma: A Post Hoc Analysis of JUPITER-06 and Meta-Analysis.

Pembrolizumab or nivolumab plus chemotherapy was approved as a first-line treatment for high programmed cell death ligand 1 (PD-L1)-expressing esophageal squamous cell carcinoma (ESCC) by the European... Post hoc analysis of the Chinese JUPITER-06 study focusing on efficacy stratified by PD-L1 tumor proportion score (TPS; using JS311 antibody) was conducted. Electronic databases were searched to ident... The post hoc analysis of JUPITER-06 showed more prominent clinical benefit with PD-1 antibody plus chemotherapy than with chemotherapy alone in both the high and low PD-L1-expressing subgroups. Five r... This study provided novel evidence supporting the superiority of PD-1 antibody plus chemotherapy to chemotherapy alone in patients with advanced ESCC with low PD-L1 expression. Further studies of pred...

Association between programmed death-1 pathway and major depression.

Major depression (MD) may be associated with inflammation and immunity. PD-1 (programmed death-1), PD-L1 (programmed death-ligand 1) and PD-L2 (programmed death-ligand 2) are among the inhibitory immu... During a period of 2 years, patients with MD and healthy controls were recruited from a medical centre in this study. The diagnosis of MD was established according to the DSM-5 criteria. The severity ... A total of 54 patients with MD and 38 healthy controls were recruited. According to the analyses, there is a significantly higher PD-L2 level in MD than in healthy controls and lower PD-1 level after ... It was found that PD-1 pathway might play an important role in MD. We need a large sample to prove these results in the future....

Programmed cell death protein 1 is a marker for neoadjuvant chemotherapy response in triple-negative breast cancer.

Tumor-infiltrating lymphocytes are detectable in up to 75% of triple-negative breast cancer. The composition of these infiltrates may influence prognosis and is not known regarding regulatory or effec... This was a retrospective observational study. Clinical and pathological data from 38 triple-negative breast cancer patients treated with neoadjuvant chemotherapy at the University Hospital (HUCFF/UFRJ... Statistically significant changes in stromal tumor-infiltrating lymphocyte categories were observed before and post-neoadjuvant chemotherapy, with 32% of intermediate cases becoming high. The correlat... In this study, we observed that chemotherapy significantly increases stromal tumor-infiltrating lymphocytes, CD8 T cells, as well as CD8/FoxP3 ratio. Most importantly, programmed cell death protein 1 ...